CARVER JENNIFER 4

What Happened
Jennifer Carver, a director of Revelation Biosciences (REVB), had 1,661 shares disposed on Feb 3, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock. The weighted average price was $1.87 (sales occurred at $1.87–$1.88), resulting in proceeds of roughly $3,106. This was a mandatory tax-withholding sale, not a voluntary open-market sell for investment reasons.

Key Details

• Transaction date: 2026-02-03; Form 4 filed: 2026-02-05 (timely filing).
• Shares sold/Disposed: 1,661 at a weighted average price of $1.87 (range $1.87–$1.88).
• Reported proceeds: approximately $3,106.
• Shares owned after transaction: not specified in this Form 4.
• Footnotes: F2 indicates the shares were sold by the issuer solely to satisfy required tax obligations (mandatory, no investment discretion). F1 notes all share counts reflect a 1-for-4 reverse split effective Jan 28, 2026. F3 explains the reported price is a weighted average across multiple sale prices; breakdown available on request.
• Transaction code: F = tax withholding (cashless sale to cover taxes).

Context
Tax-withholding sales on vesting of restricted stock are routine administrative transactions and do not necessarily indicate the insider’s view on the company’s prospects. This was not an option exercise for cash gain or an open-market discretionary sale by the director.